OKYO Pharma: Chairman's Entity Buys 35,000 Shares
Ticker: OKYO · Form: 6-K · Filed: Aug 21, 2024 · CIK: 1849296
| Field | Detail |
|---|---|
| Company | Okyo Pharma LTD (OKYO) |
| Form Type | 6-K |
| Filed Date | Aug 21, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | bullish |
Sentiment: bullish
Topics: insider-transaction, share-purchase, biotech
TL;DR
OKYO Pharma chairman's related party bought 35k shares on NASD.
AI Summary
On August 21, 2024, OKYO Pharma Ltd announced that Panetta Partners Limited, an entity with a beneficial interest held by Executive Chairman Gabriele Cerrone, purchased 35,000 ordinary shares of the Company on NASD.
Why It Matters
This purchase by an insider's related entity signals confidence in the company's future prospects and could be interpreted as a positive indicator by the market.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of an insider-related share purchase, which typically carries low immediate risk.
Key Numbers
- 35,000 — Ordinary Shares Purchased (Acquired by Panetta Partners Limited, an entity related to the Executive Chairman.)
Key Players & Entities
- OKYO Pharma LTD (company) — Registrant
- Panetta Partners Limited (company) — Purchaser of shares
- Gabriele Cerrone (person) — Executive Chairman with beneficial interest in Panetta Partners Limited
- 35,000 (dollar_amount) — Number of ordinary shares purchased
FAQ
What was the date of the announcement regarding the share purchase?
The announcement was made on August 21, 2024.
Which entity purchased the ordinary shares?
Panetta Partners Limited purchased the shares.
Who has a beneficial interest in Panetta Partners Limited?
Gabriele Cerrone, the Executive Chairman of OKYO Pharma LTD, has a beneficial interest.
How many ordinary shares were purchased?
35,000 ordinary shares were purchased.
On which exchange were the shares purchased?
The shares were purchased on NASD.
Filing Stats: 373 words · 1 min read · ~1 pages · Grade level 13.3 · Accepted 2024-08-21 07:00:14
Key Financial Figures
- $1.00 — dinary shares on NASDAQ at a price of US$1.00 per share. This brings the total shareh
Filing Documents
- form6-k.htm (6-K) — 23KB
- ex99-1.htm (EX-99.1) — 10KB
- ex99-1_001.jpg (GRAPHIC) — 26KB
- 0001493152-24-033368.txt ( ) — 71KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. OKYO Pharma LTD Date: August 21, 2024 By: /s/ Keeren Shah Name: Keeren Shah Title: Chief Financial Officer 3 EXHIBIT INDEX Exhibit No. Description 99.1 News Announcement, dated August 21, 2024 4